pathogen
virus
evolv
divers
array
mechan
avoid
impair
host
innat
immun
antivir
respons
unterholzn
almin
particularli
evad
pathway
result
type
interferon
ifn
product
signal
garciasastr
exampl
ebola
viru
ebov
reli
structur
protein
inhibit
viral
doublestrand
rna
dsrna
sens
retinoicacidinduc
protein
rigi
cardena
et
al
leung
et
al
luthra
et
al
ifninduc
doublestrand
ds
rna
sensor
protein
kinas
r
pkr
feng
et
al
schumann
et
al
thu
avoid
trigger
amplif
host
type
ifn
respons
critic
role
play
product
ebov
infect
underscor
find
mutat
introduc
disrupt
abil
sequest
viral
rna
intermedi
affect
function
ebov
replic
result
increas
type
ifn
induct
vitro
sever
attenu
viral
growth
vivo
mice
hartman
et
al
guinea
pig
prin
et
al
hostdirect
therapi
could
overcom
potent
ebov
immun
evas
strategi
would
thu
particularli
use
nitazoxanid
ntz
oral
us
food
drug
administr
fda
approv
drug
use
million
adult
children
sinc
minim
advers
side
effect
treatment
giardia
cryptosporidiumassoci
diarrhea
includ
patient
coinfect
hiv
doumbo
et
al
hussar
rossignol
et
al
ntz
circul
metabolit
tizoxanid
tiz
also
report
inhibit
divers
array
virus
tissu
cultur
small
anim
model
rossignol
human
ntz
reduc
symptom
durat
uncompl
influenza
haffizulla
et
al
viral
gastroenter
rossignol
elgohari
rotavir
diarrhea
rossignol
et
al
sever
mechan
propos
contribut
ntz
activ
specif
virus
ashiru
et
al
la
frazia
et
al
li
et
al
piacentini
et
al
rossignol
et
al
sekiba
et
al
includ
studi
show
enhanc
induct
ifnstimul
gene
isg
express
ntz
gekong
et
al
petersen
et
al
trabattoni
et
al
studi
show
weak
associ
ntz
pkr
activ
ashiru
et
al
elazar
et
al
howev
function
link
ntz
antivir
activ
specif
isg
pkr
demonstr
molecular
mechan
underli
broadspectrum
antivir
effect
host
cell
remain
unknown
show
treatment
cell
ntz
result
broad
amplif
host
innat
immun
respons
includ
increas
rigilik
receptor
rlr
activ
respons
stimul
cytoplasm
dsrna
enhanc
mitochondri
antivir
signal
protein
mav
interferon
regulatori
factor
activ
transcript
induct
antivir
phosphatas
base
data
hypothes
ntz
could
limit
overcom
ebov
abil
evad
detect
critic
innat
immun
sensor
follow
viral
entri
concentr
reflect
routin
oral
dose
parasit
infect
ntz
significantli
inhibit
ebov
replic
cell
furthermor
use
crisprdead
promot
target
ablat
express
individu
host
factor
show
ntz
inhibitori
effect
ebov
reli
rigi
pkr
indic
ntz
overcom
ebov
abil
prevent
viral
detect
cytoplasm
sensor
also
show
ntz
significantli
inhibit
second
negativestrand
rna
viru
vesicular
stomat
viru
vsv
distinct
mechan
involv
rigi
pkr
consist
differ
innat
immun
evas
strategi
employ
vsv
compar
ebov
thu
ntz
establish
broad
antivir
milieu
rapidli
amplifi
upon
viral
infect
capabl
counteract
vari
virusspecif
immun
evas
strategi
employ
ebov
vsv
effect
easili
deploy
oral
drug
treat
prevent
infect
ebov
caus
death
west
african
ebov
epidem
shiwani
et
al
claim
live
date
juli
current
outbreak
democrat
republ
congo
claud
et
al
world
health
organ
demonstr
ntz
significantli
inhibit
ebov
replic
vitro
suggest
ntz
could
potenti
role
treatment
acut
ebov
diseas
prevent
ebov
infect
expos
healthi
individu
erad
ebov
reservoir
persist
immuneprivileg
site
patient
cure
ebov
diseas
deen
et
al
provid
impetu
test
ntz
anim
model
ebov
infect
demonstr
vivo
efficaci
data
ntz
broadli
enhanc
antivir
sens
via
cytoplasm
rlr
pathway
amplifi
type
ifninduc
gene
express
includ
gene
synthesi
previous
shown
inhibit
ebov
infect
huang
et
al
led
us
specul
ntz
may
overcom
ebov
capac
evad
host
rna
sens
skirt
trigger
type
ifn
respons
basler
et
al
basler
et
al
cardena
et
al
hartman
et
al
leung
et
al
luthra
et
al
thu
favor
host
control
viru
test
hypothesi
examin
abil
ntz
inhibit
infecti
ebov
growth
human
pulmonari
epitheli
cell
vitro
biosafeti
level
condit
use
isol
infecti
ebov
origin
outbreak
democrat
republ
congo
kikwit
cell
pretreat
ntz
toxic
cell
see
figur
h
infect
ebov
moi
shown
figur
vehicleonli
treat
cell
ebov
growth
increas
log
unit
h
postinfect
contrast
time
frame
ebov
growth
complet
inhibit
cell
treat
ntz
p
drop
log
unit
initi
inoculum
titer
cell
treat
ntz
p
note
concentr
ntz
either
well
equival
peak
plasma
level
activ
metabolit
tiz
observ
human
ingest
mg
ntz
twice
day
typic
oral
regimen
cryptosporidi
diarrhea
romark
begin
character
mechan
involv
ntz
antivir
activ
next
test
ntz
effect
second
rna
viru
rhabdoviru
vsv
like
ebov
member
order
mononegaviral
also
allow
test
biosafeti
level
condit
ntz
pretreat
cell
h
inhibit
growth
firefli
luciferaseexpress
vsv
vsvluc
report
viru
cureton
et
al
cell
greater
inhibit
vsvluc
achiev
ntz
concentr
inhibit
obtain
figur
left
given
import
rigi
pkr
ebov
evas
host
antivir
respons
cardena
et
al
feng
et
al
leung
et
al
luthra
et
al
schumann
et
al
report
ntz
weakli
induc
autophosphoryl
pkr
ashiru
et
al
elazar
et
al
next
sought
determin
role
molecul
ntz
antivir
activ
use
vsv
model
system
tradit
short
hairpin
rna
shrna
base
method
gene
knockdown
includ
cell
associ
nonspecif
type
ifn
induct
shrna
reduc
shrna
activ
respons
type
ifn
stimul
machitani
et
al
chose
knockdown
rigi
pkr
express
cell
target
dead
gene
promot
see
transpar
method
figur
grna
target
sequenc
figur
protein
knockdown
effici
rigi
deplet
figur
left
panel
led
significantli
increas
vsvluc
growth
figur
right
panel
see
ntz
data
point
strong
reduct
vsvluc
sensit
ntz
inhibit
ntz
crisprctrl
cell
versu
ntz
crisprrigi
cell
figur
right
panel
deplet
pkr
figur
left
panel
also
result
significantli
increas
vsvluc
growth
figur
right
panel
ntz
data
point
howev
ntz
abil
block
vsv
replic
impair
pkrdeplet
cell
ntz
concentr
test
inhibit
ntz
crisprctrl
cell
versu
ntz
crisprpkr
cell
figur
right
panel
indic
ntz
suppress
vsv
replic
depend
pkr
phosphatas
select
promot
translat
context
host
global
translat
shutdown
follow
pkrdepend
phosphoryl
stress
pathway
activ
dalet
et
al
ntz
previous
shown
induc
low
level
endoplasm
reticulum
stress
ashiru
et
al
promot
translat
transcript
factor
elazar
et
al
translat
inhibit
transcript
activ
gene
express
hendershot
thu
investig
whether
ntz
affect
express
treat
cell
increas
concentr
ntz
h
measur
mrna
level
ntz
strongli
induc
mrna
synthesi
ntz
concentrationdepend
manner
figur
note
maxim
transcript
detect
h
postntz
stimul
cell
shown
investig
whether
particip
ntz
inhibitori
effect
vsv
knock
cell
use
strategi
describ
see
transpar
method
figur
infect
cell
figur
left
panel
vsvluc
report
viru
deplet
result
signific
increas
vsv
infectiongrowth
figur
right
panel
ntz
data
point
similar
previous
report
find
vsv
mous
embryon
fibroblast
minami
et
al
furthermor
deplet
reduc
vsv
sensit
ntz
inhibit
ntz
crisprctrl
cell
versu
ntz
cell
figur
right
panel
indic
ntz
antivsv
activ
also
depend
abil
induc
express
addit
enhanc
rigi
function
taken
togeth
although
rigi
pkr
play
role
host
inhibit
vsv
rigi
pkr
involv
ntzmediat
repress
viru
next
analyz
ebov
replic
pkrkd
cell
biosafeti
level
condit
determin
individu
role
antivir
protein
restrict
ebov
growth
rigi
pkr
deplet
led
significantli
increas
ebov
kikwit
replic
figur
increas
greater
log
unit
h
postinfect
compar
control
cell
figur
right
experi
demonstr
import
factor
host
control
ebov
infect
contrast
although
deplet
result
higher
ebov
titer
h
impact
ebov
growth
h
postinfect
figur
right
thu
unlik
found
vsv
play
limit
role
restrict
ebov
growth
cell
determin
rigi
pkr
target
ntz
requir
inhibitori
effect
upon
ebov
next
pretreat
nonspecif
control
cell
pkrkd
cell
line
ntz
h
infect
ebov
kikwit
moi
shown
figur
left
reduct
log
chang
ntz
antiebov
activ
crisprpkrkd
cell
h
postinfect
compar
crisprcontrol
cell
indic
pkr
activ
play
critic
role
ntz
efficaci
ebov
rigi
deplet
also
result
appreci
although
lesser
reduct
ebov
sensit
ntz
h
postinfect
figur
contrast
deplet
littl
effect
ntz
abil
inhibit
ebov
growth
figur
although
ntz
fda
approv
treatment
cryptosporidi
diarrhea
welltoler
medic
limit
data
present
regard
ntz
inhibit
ebov
base
vitro
studi
yet
establish
ntz
efficaci
ebov
vivo
anim
model
furthermor
detail
investig
ntz
upstream
target
regul
immun
respons
describ
outsid
scope
articl
subject
futur
studi
vivo
test
ntz
ebov
method
found
accompani
transpar
method
supplement
file
